Family Connections for Caregivers of People With Suicidal Behavior

Status Active, not recruiting

Clinical Trial Summary

The aim of our study is to verify the efficacy of the Family Connections intervention for relatives of people diagnosed with suicidal behavior disorder in a randomized control trial with a Spanish participants.

Clinical Trial Description

Family members of people who have attempted suicide feel guilty, afraid, hopeless, depression and anxiety. The needs of family members of people with suicide attempts are not adequately addressed in the current treatments for people with suicide attempts. Therefore, it is necessary to help the relatives of people with suicidal behaviors to reduce the discomfort and burden they experience by giving them information and skills to improve their relationship with patients. Family Connections (FC) is a program that has been shown to be effective in reducing burden, depression, and anxiety, and in increasing dominance and validating behaviors in relatives of people with borderline personality disorder. However, there are no Randomized Control Trials that demonstrate the efficacy of FC program in patients with suicide attempts. In a previous study, FC was adapted in an open trial with relatives of people who had attempted suicide. The results of this pilot study suggest that the FC program tailored to relatives of patients with suicide attempts may be effective in improving well-being and reducing the burden of illness in relatives. Our research team adapted FC for relatives of people diagnosed with suicidal behavior disorder (SBD) for delivery in the Spanish population. The FC-SCD program contains 12 two-hour sessions held once a week. The first aim is to verify the efficacy of the FC intervention for relatives of people diagnosed with SBD in a randomized control trial with a Spanish sample of participants from mental health services. The second objective is to analyze the feasibility and acceptance of FC-SBD in relatives. The third aim is to analyze whether the changes produced in the psychological variables in the relatives after the intervention are related to changes in the psychological variables of the patients. This paper presents the study protocol. The study design consists of a two-arm randomized controlled trial, there will be two conditions: Family Connections (FC-SBD) or Treatment as usual optimized (TAU-O). Participants will be relatives of patients who meet DSM-5 criteria for SBD. The caregivers' primary outcome measures will be the BAS. Secondary outcomes will be DASS-21, FES, DERS, QoL. The patient's primary outcome measures will be the INQ, PHQ-9, OASIS, VIRS, LUMP. Participants will be assessed at pretreatment, post-treatment, and 6-month follow-up. The intention-to-treat principle will be used when analyzing data, using mixed-effects models with full information and maximum likelihood estimation. ;

Study Design

Related Conditions & MeSH terms

Relatives

Clinical Trial Details

NCT number	NCT05157607
Study type	Interventional
Source	University of Valencia
Contact
Status	Active, not recruiting
Phase	N/A
Start date	November 15, 2021
Completion date	April 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05215392` - A Smartphone Application of "Family Connections" to Relatives of People With Borderline Personality Disorder.	N/A
Completed	`NCT04037501` - Effectiveness of a Care Management System to Reduce Unmet Needs of Informal Caregivers of People With Dementia	N/A
Recruiting	`NCT04160871` - "Family Connections": a Program for Relatives of People With Borderline Personality Disorder	N/A
Completed	`NCT04638608` - A Complex Intervention Study on a Palliative Rehabilitation Blended Learning Program to Support Relatives and Health Care Providers of People With ALS and Cognitive Impairments in Coping With Challenges	N/A
Recruiting	`NCT05404035` - "Family Connections" for Caregivers of People With Eating Disorders and Personality Disorders.	N/A
Active, not recruiting	`NCT03460483` - Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care	N/A
Recruiting	`NCT03296384` - Influence of Environmental Factors and Schizophrenia	N/A
Completed	`NCT01060761` - Involvement of Patients and Relatives in the Course of Cancer Disease	N/A
Completed	`NCT01213797` - IMTAP : Impact of the Suicide Attempt on the Nearly Entourage in Term of Traumatic Stress and Medico-economic Impact	N/A
Not yet recruiting	`NCT06100978` - Patient-reported Outcome and Patient-reported Experience After Status Epilepticus
Recruiting	`NCT06242301` - Is a Collective Person-centered Dialogue Intervention for Hospitalised COPD Patients Feasible?	N/A
Completed	`NCT03264365` - The Effectiveness of a Post-ICU Recovery Program on Relatives	N/A
Not yet recruiting	`NCT03271788` - Can Stroke Patients and Their Caregiver Benefit From Additive Mindfulness Training	N/A
Completed	`NCT03635476` - Survey of Lifelong Food and Nutrition Assistance (LIFANA) in Stroke Patients and Caregivers
Recruiting	`NCT03137420` - Psychological Distress in Relatives of Severely Injured Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.